At the molecular level, IR in PCOS is characterized by impaired insulin receptor substrate-1 (IRS-1) phosphorylation and dysregulated phosphatidylinositol 3-kinase (PI3K)/protein kinase B (AKT) signaling, leading to reduced glucose uptake and compromised metabolic insulin actions [12]. This evidence concerns the gene INS and polycystic ovary syndrome.